Prognostic Factors in Early-Stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study

Anticancer Research - Greece
doi 10.21873/anticanres.13255
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Anticancer Research USA Inc.

Related search

Stage I NSCLC: Elucidating the Prognostic Factors

Thorax
PulmonaryRespiratory Medicine
2009English

Molecular Prognostic Factors in Early-Stage Cervical Adenocarcinoma

Polish Journal of Pathology
MedicineForensic MedicinePathology
2018English

Prognostic and Predictive Factors in Early-Stage Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2004English

Prognostic Relevance of Carbonic Anhydrase-Ix in High-Risk, Early-Stage Cervical Cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2010English

SBRT for Central Tumors in Early Stage NSCLC Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

MS14.01 Basic Science Rationale of IO in Early Stage NSCLC?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Prognostic Value of CSCs Biomarker CD133 in NSCLC: A Meta-Analysis

Oncotarget
Oncology
2016English

Prognostic Biomarkers in Early-Stage B-CLL Patients

Journal of Biomedical and Clinical Research
2017English

MS27.01 Staging of Lymph Nodes in Early Stage NSCLC: Therapeutic Implications

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy